A s our understanding of the pathophysiologic processes of sepsis evolves, it becomes clear that morbidity and mortality are attributed to the type of inflammatory response launched by the host, rather than to the specific microbial trigger itself. A crucial question that has troubled clinicians for some time is why specific infections may trigger severe sepsis and death in some patients, while in others infection may be battled successfully. Recent advances in unraveling genetic variations in processes such as the innate immune response, coagulation, cell signaling, and cellular response to stress suggest that the response to inflammatory triggers, and probably susceptibility to sepsis, may be highly individualized, partially due to subtle differences in ge-netic makeup, that is, the presence of polymorphisms. Polymorphisms are natural variations in a gene, or DNA sequence, so that at least 2 alleles (alternative forms of a DNA locus) are
A s our understanding of the pathophysiologic processes of sepsis evolves, it becomes clear that morbidity and mortality are attributed to the type of inflammatory response launched by the host, rather than to the specific microbial trigger itself. A crucial question that has troubled clinicians for some time is why specific infections may trigger severe sepsis and death in some patients, while in others infection may be battled successfully. Recent advances in unraveling genetic variations in processes such as the innate immune response, coagulation, cell signaling, and cellular response to stress suggest that the response to inflammatory triggers, and probably susceptibility to sepsis, may be highly individualized, partially due to subtle differences in ge-netic makeup, that is, the presence of polymorphisms. Polymorphisms are natural variations in a gene, or DNA sequence, so that at least 2 alleles (alternative forms of a DNA locus) are
The considerable variability in septic patients' outcomes, which exceeds our understanding of the pathophysiology of sepsis and defies our current prognostic tools, has prompted investigation in the genetic variations that may predispose individuals for increased susceptibility to sepsis and adverse outcomes. This article aims to critically review current evidence from genetic association studies regarding the role of genetic polymorphisms in sepsis. Findings regarding polymorphisms in intercellular messenger mediators (cytokines), membrane-bound inflammatory receptors, intracellular signaling cascades, heat shock proteins, coagulation/ fibrinolysis pathways, apoptotic mecha-nisms, and neuroendocrine axes are presented and discussed. Study results are often discrepant, whereas many methodological limitations, in terms of both study design and genotyping methods, may render the results difficult to generalize. Nonetheless, a role for genomic variations in sepsis outcomes has emerged. A theoretical framework for incorporation of genetic variations into individualized care planning based on complexity theory is proposed, and future prospects of microarray technology and systems modelling are discussed briefly. Keywords: coagulation, complex systems theory, cytokines, polymorphism, sepsis present. In contrast to mutations, polymorphisms may be very common, involving 1% of the population or more. Polymorphisms may range from alterations of noncoding DNA sequences without any phenotypic effect, to any degree of variation with corresponding detectable phenotype alterations. Single nucleotide polymorphisms (SNPs) are allelic variations in a single base pair, due to either insertion, deletion, or substitution, and may occur in exons, introns, or promoter regions of a gene (Figure 1 ). This article aims to critically review evidence on the role of genetic polymorphisms in the pathogenesis of sepsis, based on studies conducted primarily in human and secondarily in animal subjects. A literature review of the MEDLINE and PubMed databases was carried out ( Table 1 ). The potential role of polymorphisms in essentially all the crucial pathogenetic events of sepsis will be highlighted. Implications for nursing research, practice, and theory will be discussed, as well as some future ramifications of genetics for the theory Figure 1 : A, Schematic representation of genomic variations that commonly occur in the DNA. B, Schematic representation of DNA loci where single nucleotide polymorphisms (SNPs) may occur. SNPs usually occur at the noncoding region and they do not affect gene expression. SNPs at the promoter region of the gene may affect gene expression, whereas SNPs at introns or exons may interfere with protein structure. Studies exploring polymorphisms in multiple factors appear more than once and are noted by an asterix (*). Owing to the large amount of data, studies that did not support an association are not included, although many of them are methodologically sound. (Gene Loci preceded by "-" are at the promoter region of the gene. ARDS indicates acute respiratory distress syndrome; CI, confidence interval; HR, hazard ratio; HSP, heat shock protein; IL, interleukin; MBL, mannose-binding lectin; MODS, multiple organ dysfunction syndrome; MOF, multiorgan failure; OR, odds ratio; PAI-1, plasminogen activator inhibitor-1; RA, receptor antagonist; TAFI, thrombin-activatable fibrinolysis inhibitor; PBMC, peripheral blood mononuclear cells; RR, risk ratio; TGF, transforming growth factor; TLR, toll-like receptor; TNF, tumor necrosis factor; VNTR, variable number tandem repeats).
and practice of individualized care. Finally, a preliminary theoretical framework for incorporation of genetic variations into individualized care planning based on complexity theory will be proposed. A glossary of the terms used in this article is listed in Table 2 .
The pathophysiology of sepsis is multifaceted, primarily involving altered cellular signaling due to unprecedented levels of circulating cellular mediators, which contribute to dysregulation of immunity, tissue repair, coagulation, and cellular stress responses. These highly integrated and complex processes depend on multidirectional links among most organ systems and cell types. They, therefore, constitute a multifactorial chaotic system, highly sensitive to subtle changes with unpredictable outcomes. Genomic research in sepsis aspires to pinpoint some of these subtle disparities in the circumstances of individuals that may, if not properly addressed, have significant impact on their well-being and survival when challenged by infectious agents. Herein, SNPs are represented by the initials of the nucleotides and the gene site involved, for example, a 208 G/A SNP denotes that the common allele form, at 208 bp of the gene, contains guanine (G), which is substituted by adenine (A) at the rare (polymorphic) allele. Likewise, polymorphic alleles are named with the initial of the nucleotide they carry: A, G, T (thymine), or C (cytosine).
A Comment on Methodology of Genetic Association Studies in Sepsis
Genotype association studies in sepsis are proliferating; nonetheless, the exploration of the association of polymorphisms with the incidence and outcome of sepsis has often provided conflicting results. 1,2 Peters et al 3 through a systematic review and secondary analysis of banked genetic material highlighted that common methodological errors may lead to failure to confirm genotype, thus jeopardizing the validity of studies. Furthermore, a number of methodological limitations (sampling method, sample size, multiple confounding variables, inadequate statistical models, low reliability of methods, inadequate case-control matching) evident in many of these studies may limit generalizability and internal validity, thus rendering the inference of relationships between allelic variations and clinical outcome problematic. In addition, hard evidence suggests that some of the alleged pathogenetic polymorphisms may not be functional, leading to the conclusion that significant polymorphisms may still elude detection obscured by their less important linkage disequilibrium counterparts. Indeed, following a systematic evaluation of genetic association studies in human diseases, Bogardus and colleagues 4 concluded that many of these attempts failed to follow standard rules of epidemiological research methodology, in accordance with a recent meta-analysis. 5 An additional confounder lies at the different ethnic backgrounds of the populations studied. Polymorphisms may exhibit significant interethnic variability; therefore, genetic association results may not be easily transferable across different ethnicities. In addition, factors already known to affect outcome, such as age, gender, 6 comorbidities, type of organism and site of infection need to be taken into account. Furthermore, individuals may carry multiple allelic polymorphisms, either by chance or due to linkage disequilibrium, which may act as major confounders. Vitali and Randolph 7 provide a comprehensive summary of methodological standards for case-control genetic association studies. Nonetheless, even well-designed studies exhibiting associations of SNPs with sepsis cannot establish causality. More investigation is needed in order to elucidate some of these complex multivariate associations in a way that may be proven meaningful clinically. Our increased awareness of the multiple simultaneous, often nonlinear, interactions in sepsis, will probably render some of our traditional statistical modeling approaches obsolete. Extended multidisciplinary efforts may be needed to decipher the role of genetic makeup in sepsis.
Cellular Messenger Polymorphisms
Cytokines are peptides produced by diverse types of cells (including immune, endothelial and nervous cells), which act as cell-to-cell messengers to regulate diverse processes, including immunity, inflammation, and cellular response to adverse conditions. 8 Cytokines account for the high level of integration of inflammatory responses, including bidirectional links with the CNS, endothelia and organ system responses. Cytokine polymorphisms have been implicated in the pathogenesis of many diverse disease states. 9 Genetic variations in 
Allele
Alternative forms of a genetic locus; a single allele for each locus is inherited from each parent separately
Apoptosis
Programmed cell death, the body's normal method of disposing of unwanted, or unneeded, cells 198, 199 CD14 CD14 is a surface protein preferentially expressed on monocytes/ macrophages. It binds lipopolysaccharide binding protein and, recently, it has been shown to bind apoptotic cells
Exon
The protein-coding DNA sequences of a gene Genome All the DNA contained in an organism or a cell, which includes both the chromosomes within the nucleus and the DNA in mitochondria 198, 199 Genotype
The genetic identity of an individual that does not show as outward characteristics 198, 199 Haplotype Set of genes at more than 1 locus, which is inherited from one of the parents Haplotype clade Set of genes that has branched from a specific ancestor haplotype and may have been altered through time because of various recombination events Heat shock proteins HSPs, also called stress proteins, are induced under cellular stress conditions, such as oxygen deprivation, oxidative stress, temperature elevation, and cytokine stimulation. Also, they are involved in protein folding and protection from damage Homozygous Possessing 2 identical forms of a particular gene, 1 inherited from each parent 198, 199 Intron A segment of DNA (between exons) that is transcribed into nuclear RNA, but is removed in the subsequent processing into mRNA
In vitro An experimental situation outside the organism. Biological or chemical work done in the test tube (literally, in glass) rather than in living systems 198, 199 In vivo An experimental situation inside the organism. Experimental subjects are living systems
IRAK4
Interleukin-1 receptor-associated kinase 4
Kinase
An enzyme that transfers a phosphate group from ATP to another molecule Linkage disequilibrium A condition where alleles occur together more often than can be accounted for by chance. Indicates that the 2 alleles are physically close on the DNA strand the proinflammatory cytokines TNFA, TNFB, and IL6 and the anti-inflammatory cytokine IL10 are the most extensively studied in relation to sepsis. Remarkably, patients predisposed to produce a balanced anti-, proinflammatory response appear to have better chances for survival in multiple organ dysfunction syndrome (MODS) and sepsis. 10
Tumor Necrosis Factor-␣
Tumor necrosis factor-␣ (TNFA) is a cardinal mediator of sepsis 11 and one of the initial triggers in the activation and regulation of immune responses. Nonetheless, studies examining its levels and association with survival and severity have had conflicting results. 12 Recent evidence suggests that TNFA gene variations may in part predispose patients for increased severity, 13 which is sometimes, 14, 15 but not always, 16 associated with altered TNFA levels. In addition, TNFA polymorphisms may occur in linkage with TNFB variations, 17 presumably increasing individual risk for septic shock. 18 Many different SNPs have been detected at the promoter region of the TNFA gene, 19 of which those relevant to sepsis appear to be -308 G/A, -376 G/A, and -238 G/A transitions. 20 The -308 G/A was the first to be identified and the most widely studied. 21 The common allele form (TNF1) contains guanine (G), and the uncommon one (TNF2) adenine (A). 22 However, evidence suggests that the TNF2 polymorphism may not be functional, 23, 24 in contrast to in vitro studies that showed increased TNFA produc-tion. 25, 26 Evidence on the rest of the TNFA polymorphisms is controversial. 21 The significance of the -308 G/A TNFA SNP has been demonstrated through increased detection of the TNF2 allele and an associated increased risk for death in French and Australian medical ICU patients with sepsis, 13, 27 as well as in North American trauma/surgical ICU patients, 28, 29 although the association with mortality was not always significant. Furthermore, increased frequency of the TNF2 allele, which was associated with increased mortality and uncontrollable IL6 levels was reported in a mixed group of Japanese critically ill individuals, 30 while in Swedish cardiac surgery patients it was associated with higher peak TNFA and IL6 levels and increased risk for multiple organ dysfunction. 31 In acute respiratory distress syndrome patients, the TNF2 allele was associated with increased mortality. 17 However, recent studies failed to show significant associations of TNFA polymorphisms with either disease severity, susceptibility to sepsis or patient outcomes in white and Chinese adults, 14, [32] [33] [34] [35] and Hungarian septic infants. 36 In addition, no association was detected with pancreatitis-related sepsis in 2 Chinese studies. 22, 37 Nevertheless, methodological limitations, such as small convenience samples and univariate analyses may have limited the validity of these results. In addition, evidence that the TNF2 allele was associated with increased risk for septic shock only when accompanied by a TNFB polymorphism 27 suggests 
Polymorphisms
Natural variations in a gene, or DNA sequence, so that at least 2 alleles (alternative forms of a DNA locus) are present Promoter A site on DNA to which RNA polymerase will bind and initiate transcription.
SNPs
Allelic variations in a single base pair. Variations occurring at the promoter region of a gene are labeled with a "-" sign, eg, a -208 SNP means that a polymorphism occurs 208 bp before the start codon TIR Toll/interleukin-1 receptor (TIR) domain is the conserved intracellular domain of the 2 families of receptors. It is believed that a TIR domain signaling complex is formed between the receptor and the adapter TIR domains
Toll-like receptor Toll-like receptors (TLRs) are type I transmembrane proteins involved in innate immunity by recognizing microbial conserved structures VNTR Variable-number tandem repeats: any gene the alleles of which contain different numbers of repeated oligonucleotide sequences that multifactorial models need to be explored in order to clarify the significance of TNF polymorphisms in sepsis.
Tumor Necrosis Factor-␤
Tumor necrosis factor-␤ (TNFB or LTA) binds to the same receptor as TNFA, and a number of polymorphisms have been described, 38 of which the 250 G/A at the first TNFB intron is the one most extensively studied in relation to sepsis. 27 Kahlke et al 39 investigated 160 German patients undergoing major gastrointestinal surgery and concluded that the presence of a length polymorphism at an NcoI restriction fragment (which originates after specific DNA cleavage by the restriction endonuclease NcoI) in the TNFB gene associated with increased risk for postoperative complications at the heterozygous state, and with increased risk for severe complications, sepsis and mortality at the homozygous state, in agreement with previous results. 40 In addition, the presence of the TNFB A allele was associated with increased risk for cardiac and respiratory dysfunction in 95 Swedish cardiac surgery patients, 31 and increased mortality in British patients with MODS. 10 Moreover, homozygocity for the TNFB 250 SNP was associated with increased risk for sepsis after trauma in Dutch patients. 35, 41 However, in a German study of 85 critically ill patients postsurgery no association between the incidence of the TNFB 250 SNP and outcome was observed. 42 Likewise, the incidence of sepsis, septic shock, and mortality was not increased in patients with systemic inflammatory response syndrome (SIRS) bearing the TNFB 250 SNP in a North American study. 34 Further confounding any inferences regarding the association of TNFB polymorphisms with sepsis, TNFB SNPs are in linkage disequilibrium with heat shock protein 70 (HSP70) alleles. An adenine at both the 250 TNFB and HSP70A1B 1267 gene sites is associated with greater risk for septic shock after trauma 43, 44 and mortality in severe sepsis. 45 Therefore, examination of potential linkage disequilibrium occurrences and multifactorial models may be necessary before any inferences for the role of TNFB variability in sepsis can be made.
Interleukin-1␤, Interleukin-1␣
Interleukin-1 (IL1; another central mediator of inflammation) occurs in 2 forms: IL1A and IL1B. An SNP is present at the -511 promoter region of the IL1B gene, which is in linkage disequilibrium with another promoter SNP at -31. 46 Through a multivariate exploration of 1106 British patients with meningococcal meningitis, the -511 SNP at the promoter of IL1B appeared to contribute to mortality. 46 However, there was no association between IL1B 3594 C/T SNP and severe acute pancreatitis and ensuing septic shock in a Chinese study, 47 and between the IL1B 3953 C/T SNP and disease severity in meningococcemia in an Irish study, 33 as well as between the -511 IL1B promoter SNP and susceptibility to sepsis in a Chinese study, 48 and in a German study. 49 However, homozygocity for a specific variable-number tandem repeat (VNTR) at exon 5 of the IL1B gene was associated with increased mortality in Chinese patients with sepsis. 48 Less evidence exists on the role of IL1A polymorphisms in sepsis. Polymorphic regions with VNTRs are detected within intron 6 of the IL1A gene. Alleles are designated A1, A2, A3, A4, and A5 on the basis of their relative frequency in healthy populations. 43 Ma and colleagues 48 reported that Chinese patients homozygous for a specific intron 6 VNTR of the IL1A gene (A2) are at significantly higher risk for death; nonetheless, they did not observe higher frequency of this allele in patients with sepsis, in contrast to previous results by Fang et al 49 in Germans. An additional study failed to show increased incidence of A2 in Spanish patients with sepsis and pneumonia. 50 In summary, results on the role of IL1 polymorphisms are highly variable, presumably due to the many methodological limitations of association studies, and the diverse ethnic background of the populations studied. At the present state of the art, conclusions on the role of IL1 variability in sepsis must be drawn with great caution.
Interleukin-6
Interleukin-6 (IL6) plays a role in lymphocyte stimulation and its levels appear to associate with severity and mortality in sepsis, consistently. 51 Genotype differences in the IL1, TNFA, and HSP70 genes have been implicated in regulating differential peak IL6 levels in SIRS, 30, 52, 53 whereas multiple allelic variations have been detected in the IL6 gene: a -174 G/C at the promoter region, a 1753 C/G, and a 2954 G/C. 20 The -174 G/C SNP was shown to be functional in vivo in white volunteers 54 ; however, no association with the ex vivo IL6 response was observed in Dutch trauma victims. 55 In a study of 326 German surgical patients, the -174 G/C SNP was found to be associated with survival in sepsis but not with the incidence of sepsis, 56 whereas it was associated with survival in meningococcemia in an Irish study. 33 Haplotype clades bearing specific SNPs (-174 G/C, -1753 C/G, and -2954 G/C) were reported to associate with mortality and susceptibility to MODS in 228 white patients with SIRS. 57 By reviewing evidence through a candidate gene approach, IL6 was shown to be involved in acute lung injury 58 ; however, no association between the -174 G/C SNP and severity of pneumonia was detected in an Irish study. 59 In summary, it is possible that genetic variation at the IL6 gene may contribute to the outcome of sepsis; nonetheless, variable association of specific SNPs with IL6 levels and the potential presence of linkage disequilibrium with several alleles still obscure the clinical significance of these results.
Interleukin-10
Interleukin-10 (IL10) appears to be an integral part of the body's anti-inflammatory processes, since its production is stimulated by inflammation, and it is a potent inhibitor of nonspecific inflammatory responses. In sepsis, high IL10 levels associating with severity have been reported, consistently. 60, 61 Interleukin-10 is highly polymorphic, 62 and at least 3 SNPs at the promoter region (-1082, -819, and -592, of which the latter 2 are in linkage disequilibrium) have been implicated in sepsis. 63 Lowe et al 64 explored the incidence and effect of these promoter SNPs, and of 2 dinucleotide repeats in 67 Scottish critically ill patients and 132 volunteers. Presence of the -592 C/A SNP was found to be associated with lower stimulated IL10 release and higher mortality. No association was observed regarding the rest of the polymorphisms. In addition, in a Japanese population, concurrence of the IL10 -592 C/A with the TNFA -308 G/A SNP increased the risk for sepsis. 65 However, in a Canadian study, the 592G/734G/3367G haplotype was found to be associated with increased mortality and organ dysfunction in patients with pulmonary, but not extrapulmonary, sepsis. 66 A G/A substitution at -1082 bp has been associated with severity of meningococcemia in an Irish sample, 33 and with lower ex vivo IL10 production and susceptibility to sepsis. 67 Conversely, it was the IL10 -1082 G allele that appeared to be associated with increased risk for sepsis in Chinese samples, 47, 68 and increased severity of SIRS in an Irish sample. 59 Nonetheless, in an American study of patients with acute renal failure, the IL10 -1082 G allele was associated with lower mortality when adjusting for multiple organ dysfunction severity. 69 The IL10 -1082 G allele has been associated with higher stimulated levels of IL10 in Caucasian critical care patients. 70, 71 Results from a British study support the hypothesis that low IL10 producer genotypes may be implicated in multiple organ dysfunction. 10 In conclusion, evidence on the role of IL10 gene variations in sepsis is highly variable. Ethnicity is an obvious confounder; nonetheless, more well-designed association studies are needed.
Interleukin-1 Receptor Antagonist
Interleukin-1 receptor antagonist (IL1RN) antagonizes the proinflammatory actions of IL1A and IL1B by binding to their receptor. 72 Variable-number tandem repeats have been described in the IL1RN gene. Arnalich et al 50 evaluated the presence of 5 different VNTRs of various sizes at the IL1RN intron 2 in Spanish patients with severe sepsis, and concluded that homozygocity for 2 repeats of 250 bp associated with higher mortality (after adjusting for APACHE II scores), and lower ex vivo IL1RN production. Similarly, in Chinese populations, the same VNTR allele was associated with increased susceptibility to 49 and severity of sepsis. 48 Hence, although not as extensively studied, IL1RN polymorphisms may be promising candidates for genetic associations in sepsis; nonetheless, they should be explored in relation to the rest of IL1 peptides.
Some evidence exists for other cytokine polymorphisms as well, including the proinflammatory IL18, 73 interferon-␥, 74 and pre-B-cell colony-enhancing factor. 58, 75, 76 Nonetheless, owing to the absence of sufficient investigation, such results should be considered preliminary.
Pathogen Recognition/Signaling Molecule Polymorphisms
Toll-like receptors (TLRs) are transmembrane receptors, expressed primarily on immune and epithelial cells, that recognize pathogen-associated molecular patterns (PAMPs), thus initiating and sustaining the inflammatory response. 77 They constitute the major mechanism for microorganism detection, and initiate a little understood complex cascade of kinases and multiple adapter molecules. 78 Recognition of PAMPs often requires the presence of accessory molecules such as CD14 or MD2. 79 Tolllike receptors exhibit some specificity in pathogen recognition: TLR2 appears to be involved in recognition of gram-positive and TLR4 in recognition of gram-negative bacteria. 80 Pathogen-associated molecular patterns recognition takes place either at an extracellular or at an intracellular domain. Following PAMP recognition, intracellular signaling is carried out through a cytoplasmic domain (TIR), which through recruitment of specific intracellular proteins (eg, MyD88, TIRAP/ MAL, TRAM, TRIF) enhances translocation of the transcriptional activator NF-kappaB (NF-B) into the nucleus, thus promoting the expression of specific cytokines and other pertinent molecules. 20, 79, 81 Two of the 10 TLRs identified in humans have been explored in relation to the genetics of sepsis: TLR2 and TLR4, the latter of which is the most widely investigated, along with the accessory molecule CD14.
Toll-like Receptor 4
Preliminary evidence for the role of TLR4 in sepsis was provided by animal studies demonstrating that the long-known hypo-responsiveness of a common laboratory mouse strain (C3H/HeJ) to endotoxin (lipopolysaccharidae [LPS], cell-wall component of gram-negative bacteria) was attributed to a mutation in the TLR4 gene. 82 Furthermore, Arbour and colleagues 83 showed that 2 common SNPs at the TLR4 gene (896 A/G, or Asp299Gly, and 1196 C/T, or Thr399Ile) account for attenuated in vivo responses to inhaled endotoxin and for in vitro hyporesponsiveness of immune and airway epithelial cells in humans. The 896 A/G SNP appears to be quite common in whites, 84 but it may be less frequent among individuals of Asiatic descent. 65 However, monocytes of individuals bearing this G allele showed no deficit in LPS signaling, 84, 85 probably suggesting the existence of alternative molecules and/or signaling pathways, thus undermining the clinical significance of these SNPs in sepsis. Nonetheless, an association with the incidence of gram-negative infection 86, 87 and the susceptibility to septic shock 87 in North American critical care patients, and a potential trend for higher mortality in a UK critical care patient population 88 have been reported. Similarly, in North American burn victims, the 896 A/G SNP imparted an increased risk for severe sepsis, after adjustment for clinical parameters, gender, and ethnicity. 89 Nevertheless, no association between the 896 A/G SNP (G allele) and risk for meningococcal disease were observed in a British 90 and a Gambian pediatric 91 sample. In summary, the hypothesis that genomic variations in the TLR4 gene predispose individuals for sepsis, along with the possible mechanisms that mediate altered immunity, merits further exploration.
Toll-like Receptor 2
Toll-like receptor 2 (TLR2) appears to be involved in staphylococcus signaling 92 ; however, studies examining susceptibility to Staphylococcus aureus infections in the presence of 2 common TLR2 SNPs in whites had conflicting results 93, 94 However, a -16933 T/A SNP was associated with increased incidence of positive cultures and gram-positive bacteria in a Canadian population of SIRS patients. 95
CD14
CD14 is a ubiquitous pattern recognition receptor, specific for LPS and a variety for other ligands, expressed primarily on immune and endothelial cells, 96 the gene of which exhibits considerable interethnic variability. 97 It acts as a coreceptor for TLR4, and a soluble form (sCD14) is shed by monocytes to facilitate LPS signaling for all other cells. 96 Two polymorphisms at the promoter region of the CD14 gene (-159 C/T and -260 C/T) are the most widely explored in inflammatory diseases. The -159 C/T SNP (T allele) has been associated with increased detection of both membrane-bound CD14 on monocytes and circulating levels of CD14 98, 99 ; nonetheless, the role of both SNPs in the pathogenesis of sepsis remains unclear.
In a Canadian study, the -159 C/T SNP (T allele) was associated with increased prevalence of gram-negative infections and sepsis, but not with the prevalence of septic shock or survival. 95 Likewise, in a French multicenter study, an association with mortality was reported. 100 Nonetheless, in a North American ICU population Agnese et al 86 did not observe any association between CD14 SNPs and incidence of infection, and in a Japanese sample 65 no association with sepsis was observed. Similarly, in a German study exploring 204 patients with severe sepsis and 247 controls, no association between the -159 C/T SNP and sepsis was detected. 101 Furthermore, Zhang et al 47 reported no association between the -159 C/T SNP and severe acute pancreatitis and septic shock, and Barber et al 89 no association with sepsis in burn trauma.
Recently, the -260 C/T CD14 SNP (T allele) has been linked to increased survival in critically ill patients in a Southern Brazilian population. 102 The -260 C/T SNP has also been implicated in atherogenesis and cardiovascular events. 103 Furthermore, although evidence on the role of CD14 is conflicting, clinical studies are exploring the efficacy of a chimeric monoclonal antibody (IC14) against human CD14 in patients with severe sepsis. 104
Mannose-binding Lectin
Mannose-binding lectin (MBL) is a circulating serum protein that recognizes and binds carbohydrate structures on the surface of infectious agents and activates the complement system through MBL-associated serine proteases. 105 Interindividual differences of serum MBL are mainly caused by structural variant alleles in the MBL gene, 106 and MBL deficiency has been linked to increased risk of infections in early childhood 107 and of sepsis in critically ill adults. 108 Point mutations at exon 1 resulting in 4 different variant alleles, and an SNP at the promoter region -221, have been described. 109, 110 In a Danish study, the presence of MBL variant alleles and promoter alleles was associated with the development of sepsis, severe sepsis, septic shock, and mortality in 272 patients with SIRS, 111 and it was suggested that substitution therapy may be tested for sepsis prophylaxis. Similarly, Sutherland et al 95 reported that the presence of MBL alleles was associated with increased risk for positive bacterial cultures. Furthermore, in British patients, the presence of variant alleles was associated with susceptibility to sepsis and septic shock in 174 adult patients with sepsis, 109 and with low levels of MBL, and increased risk of SIRS, sepsis, and septic shock in 100 critically ill children. 112 Nonetheless, in a random sample of 141 adult Danish patients with cultures positive for Streptococcus pneumoniae, no association with susceptibility to sepsis and patient outcomes was observed. 113 In summary, preliminary evidence potentially supports a role for MBL polymorphisms in sepsis susceptibility; nonetheless, further investigation is needed to replicate these findings in different populations.
Genetic polymorphisms involving the Fc␥ (FCG) leukocyte receptors, which are involved in opsonization and phagocytosis of bacteria, may also be significant in sepsis. Polymorphisms in the FCGR2A and FCGR3B receptors have been linked to increased susceptibility to meningococcal disease, 114, 115 and to meningococcemia-related sepsis and shock. 116, 117 Nonetheless, the association of FCG polymorphisms with nonmeningococcal sepsis is unclear.
Intracellular Signaling Molecules
Following TLR engagement, defects of the pathway for the translocation of the transcription factor NF-B into the nucleus to intitiate expression of inflammatory mediators may alter individual susceptibility to infection. The IL1 receptor-associated kinase-4 (IRAK4) is an intracellular kinase that transduces intracellular signals conveyed by the TLRs and IL1 receptors. 118 Three human immunodeficiencies associated with impaired TLR signaling have been described, which are linked with developmental defects. 119 Patients with IRAK4 deficiency are at increased risk for invasive disease due to pyogenic bacteria, 120 but present no developmental defects. Homozygocity for either of the 2 variant alleles appears to inhibit expression of IRAK4 in humans, thereby inhibiting activation of NF-B, 121 which is in particular involved in LPS signaling. 122 The presence of a newly characterized splice variant of IRAK4 (IRAK1c), which inhibits NF-B activation, 123 adds further complexity to the intracellular signaling system of pathogens. No genetic association studies for this intracellular pathway in septic patients have been located.
Programmed Cell Death Polymorphisms
Widespread triggering of apoptosis, at least in lymphoid tissues, has been implicated in the pathophysiology of MODS and sepsis 124, 125 ; however, the association with nonlymphoid tissue apoptosis is less compelling. 126 Apoptotic loss of immunocytes may contribute to the immunological derangements, and hyporeactivity observed in sepsis and MODS, 127 whereas neutrophil resistance to apoptosis appears to promote neutrophil aggregation and subsequent microcirculatory and oxidative damage. 128, 129 Moreover, in vivo silencing of pro-apoptotic genes appears to rescue septic mice. 130 Apoptosis-related polymorphisms have been studied extensively in relation to cancer susceptibility (eg, Wu et al) 131 ; nonetheless, the investigation of variations in apoptotic genes in sepsis is very limited. Caspaces mediate proteolysis in inflammation and intracellular apoptotic signaling. An SNP in the human caspase-12, detected in individuals of African descent, has been implicated in hyporesponsiveness to LPS, but not with alterations in apoptotic sensitivity. 132 Polymorphisms in the gene of the apoptotic receptor Fas have been associated with the severity of hepatitis C in humans, 133 and apoptotic gene polymorphisms with the response to Salmonella enteritidis in poultry. 134 Given the presence of multiple SNPs in apoptotic pathway genes in humans, their involvement in sepsis merits investigation.
Cellular Stress-Protein Polymorphisms
Heat shock proteins (HSP) are phylogenetically primitive proteins that are expressed in response to cellular stress and are involved in diverse responses including cellular dormancy and protein repair. Some HSPs are expressed constitutively in nonstressed cells and they are essential for protein compilation and generation of protective cellular responses. 135 In animal models of sepsis, induction of HSPs reduces organ dysfunction and mortality. 136, 137 In patients with severe sepsis, the heat shock response appears to be activated, 138 and an impairment of the ex vivo LPS-inducible 70-kD HSP (HSP70) expression in lymphocytes was observed, 139 which may be implicated in immune dysfunction. 140 There are 3 adjacent genes in the HSP70 family: HSPA1A, HSPA1B, and HSPA1L, of which the first 2 encode the same and the third one a highly homologous protein. 141 Waterer et al 44 reported that homozygocity for a polymorphism in HSPA1B (1267 G/A) was a strong predictor of septic shock in patients with community-acquired pneumonia. However, Schroeder et al detected no association between 2 biallelic polymorphisms in HSPA1A and HSPA1B and the susceptibility or outcome of sepsis. 45 Nonetheless, although the HSPA1B 1267 A/G SNP is silent, it is in linkage disequilibrium with a HSPA1B -179 C/T polymorphism that accounts for lowered production of HSP70, and therefore may be involved in susceptibility to sepsis. 141 Moreover, polymorphisms in HSPA1B and HSPA1L and TNFA and IL6 concentrations, respectively, as well as the outcome of severe injury were found to be associated in a German study. 53 In summary, evidence on the role of HSP polymorphisms in sepsis is scarce, implying the need for further investigation.
Coagulation Protein Polymorphisms
Activation of coagulation, a response integrated with inflammatory triggering, is a key pathogenetic event in sepsis. Increased coagulability, along with decreased fibrinolysis and consumption of coagulation inhibitors lead to fibrin deposition in the microvasculature. 142, 143 Abnormalities in the antithrombin III, activated protein C (APC), and tissue-factor inhibitor pathways have been implicated in the pathogenesis of sepsis, 144 and administration of recombinant human APC appears to be effective for the reduction of mortality in clinical trials with patients with severe sepsis. 145 A plethora of studies focused on the role of hemostatic gene polymorphisms in cardiovascular diseases and provided worth noticing associations, but, most likely, moderate evidence. 146
Plasminogen Activator Inhibitor-1
Plasminogen activator inhibitor-1 (PAI1) is involved in inhibition of both tissue-and urokinase-type plasminogen activators, promoting the stability and extension of the clot and increasing clot resistance to lysis, 144, 147 and acts as an acute-phase protein in inflammation. 148 Increased expression of PAI1 is considered as a risk factor in cardiovascular disease, 148 and may associate with survival in meningococcal septic shock. 149 The functional 4G/5G insertion/deletion polymorphism at -675 of the promoter region is the one most extensively investigated in sepsis. Individuals homozygous for the 4G allele have significantly higher plasma activity of PAI1 compared to 5G homozygotes. 150, 151 In a multicenter study exploring 347 Central European and British children with systemic meningococcemia, the homozygous 4G/4G genotype conferred a greater risk for sepsis (odds ratio [OR] ϭ 2.21) and mortality (OR ϭ 2.31), although there was no association with the probability of meningitis. 152 Likewise, in a case-control study of British children with meningococcal disease, an increased risk for death (OR ϭ 1.9), death from sepsis (OR ϭ 2.7), and increased risk for vascular complications in survivors (OR ϭ 2.4) were observed in 4G/4G homozygotes. 153 These results are in accordance with a previous study of Dutch and British children. 151 In a Dutch study of patients with meningitis, presence of the 4G/4G allele in relatives of diseased patients was associated with increased risk for septic shock (OR ϭ 5.9), although there was no association with the susceptibility to meningitis. 154 Likewise, in a smaller Chinese study, the 4G/4G genotype was associated with greater risk for sepsis from all causes and mortality, 155 similar to the results in a recent Turkish study. 156 Moreover, poorer survival after severe injury has been associated with the 4G/4G genotype. 157 In summary, the evidence reviewed herein suggests an association of PAI1 genotypes and outcome of sepsis, especially meningococcal sepsis, and may be of great importance for pediatric critical care.
Factor V
Polymorphisms in the factor V (FV) gene may interfere with its proteolytic degradation by APC through altering proteolytic sites, thus rendering factor Va partially resistant to inactivation by APC. Commonly (5% of whites, approximately), but with significant ethnic heterogeneity, 158 1691 A/G SNP in the factor V gene (FV Leiden) has been implicated in the pathogenesis of sepsis. The high prevalence of FV Leiden in certain populations has prompted the hypothesis that this SNP may confer some evolutionary advantage. Studies with mutant FV Leiden mice showed increased survival following septic challenges. 159, 160 Furthermore, secondary analysis of data of patients involved in a multicenter clinical trial of APC revealed a trend for increased survival following APC administration and for decreased susceptibility to sepsis in FV Leiden carriers. 161 Nonetheless, in a Danish prospective cohort study of 9253 individuals, although heterozygocity for FV Leiden was not associated with increased risk for sepsis, an increased risk for mortality in FV Leiden carriers with sepsis was observed. Likewise, in FV Leiden carriers, the risk for urinary tract infections appeared to be decreased and the risk for skin infections to be increased. 162 In a British study of 259 children with meningococcal disease, heterozygocity for FV Leiden was associated with increased risk for purpura fulminans. 163 In conclusion, the factor V Leiden polymorphism appears to be associated with increased risk for coagulation disorders; nonetheless, its role in sepsis is as yet uncertain.
Thrombin-activatable fibrinolysis inhibitor (TAFI), a peptidase activated by thrombin, is a potent inhibitor of fibrinolysis. In a Dutch study involving 50 patients with meningococcemia, a specific polymorphism of the TAFI gene was associated with increased risk for meningococcal disease mortality. 164 Nonetheless, no further evidence on the role of TAFI polymorphisms in sepsis was located. Genetic polymorphisms of other constituents of the coagulation/fibrinolysis pathways may warrant investigation; nonetheless, despite their exploration in the context of thrombosis and cardiac disease (reviewed in reference 144), evidence regarding their involvement in sepsis is limited.
Stress Hormone Polymorphisms
Studies in populations of critically ill patients have provided evidence of the striking alterations in the hypothalamic-anterior pituitary axis hormones, and of their association with severity and mortality. 165, 166 Targeted endocrine interventions, including physiologic corticosteroid replacement therapy and intensive insulin therapy appear to improve survival in sepsis. 167, 168 Nonetheless, investigation of neuroendocrine responses in sepsis is limited. Inflammatory responses are highly integrated with neuroendocrine activation, 169 and these 2 mechanisms should not be studied in isolation.
Multiple polymorphisms have been described in components of the hypothalamicpituitary-adrenal (HPA) axis, which is fundamental for the response to the stress of sepsis. 170 For example, an adrenocorticotropic hormone (ACTH) receptor promoter polymorphism appears to lead to decreased adrenal responsiveness to ACTH, 171, 172 which may be of essence for these individuals' response to septic challenges. In addition, corticosteroidrelated gene polymorphisms may interfere with stress and metabolic responses, [173] [174] [175] and polymorphisms in genes encoding for peptides that hydrolyze cortisol may account for sustained plasma cortisol levels, interfering with cardiovascular regulation. 176 Furthermore, a pro-opiomelanocortin polymorphism may associate with serum levels of leptin, 177 a metabolism-regulatory peptide that is elevated in MODS and sepsis. 178, 179 In addition, functional polymorphisms of the growth hormone (GH) gene, a hormone central for the neuroendocrine response to sepsis, 166 have been described in humans. 180 At present, hormone polymorphisms have not been investigated in Figure 2 : Endothelial cell response as a model for the involvement of genetic polymorphisms in sepsis. Genetic polymorphisms may be involved in multiple aspects of cellular response and inflammation/ recovery mechanisms in sepsis (dotted circles). a, b: pathogen recognition through transmembrane receptors; c: intracellular signaling following pathogen recognition; d: immunocyte clonal expansion and development of immune responses; e: coagulation/ fibrinolysis and complement activation events; f: heat shock protein expression and cellular hibernation in response to cellular stress; g: production of proand anti-inflammatory cytokines, h: triggering of apoptotic cell death (immunocytes, endothelial cells), i: production of hypothalamic-pituitary stress hormones. APC indicates antigen-presenting cell; CD14, pathogen recognition accessory molecule; CTL, cytotoxic T cell; HSP, heat-shock proteins; IL, interleukin; M⌽, macrophage; NK, natural killer cell; TLR, toll-like receptor; and TNF, tumor necrosis factor. relation to sepsis, despite the pivotal role of neuroendocrine responses for patient survival.
Synthesis and Proposed Framework
Despite obvious discrepancies and methodological limitations, taken together, these data suggest that genomic variations may have a role in shaping individual susceptibility to sepsis and/or individual risk for septic complications and death. Genomic variations may interfere with multiple aspects of recovery and cellular response mechanisms in sepsis ( Figure 2) . Such evidence corroborates a long-held premise of nursing theory and practice: individualized care. Individualized care involves nursing care activities based on individual patients' needs, and encompasses diverse dimensions, such as nursing ethics, interventions, and patient education. 181 However, the concept and correlates of individualization of care may remain obscure, 182 whereas, often, it has been equated to offering choice to patients and to patient autonomy. 183 Nonetheless, individualized care is a much broader concept grounded on the hypothesis that patients' responses to disease may vary according to specific individual differences, which, when properly addressed, increase chances for improved patient outcomes. Evidence originating from genetic research, for the first time, offers an extended biological foundation for the theoretical concept of individualized care. In the future, genomic variations may guide specific individualized strategies of care for patients at risk for (and/or with) sepsis based on the identification of a wide array of genetic characteristics. However, genetic research in sepsis is unlikely to produce any clinically meaningful results, if the multifactorial nature of sepsis and inflammation is not taken into account for the design of genetic association studies and of tailored clinical trials. The disappointment with the administration of antimediator therapies, 184 over the past years, has fueled the argument that linear cause-effect dynamics may not apply to exceedingly multifactorial phenomena such as sepsis. Conversely, complex nonlinear systems, governed by the laws of chaos-where small perturbations in 1 variable are likely to affect all other variables and their interactions-are proposed as a new paradigm for sepsis. 185, 186 In such a model, the interconnections among variables, which form an expanding dynamic web of events, are more important than the variables themselves. 185 Interconnections within the web amplify minor variations in such a way that system outcomes may diverge largely because of subtle differences in initial conditions (sensitive dependence on initial conditions), for example, the presence of a few allelic variations. Within this paradigm, nursing and medical care have the potential to attract the system to an outcome by inflicting targeted minor changes to initial conditions. Therefore, theoretically, knowledge of individual variations early on, before the organism takes the path of MODS and death, and targeted therapeutic adjustments may lead individual illness trajectories to desired outcomes. Nonetheless, major advances in diagnostics and therapy, new approaches to mathematical modeling, and a giant leap in the paradigm of care from linear to complex are needed before individualized care plans can address genetic variation. Microarray technology may provide a means for accurate genotyping of hundreds of SNPs, simultaneously, 187, 188 and a means for detecting and quantifying equally large groups of peptides in plasma. 189, 190 In addition, recent advances in dynamical sepsis modeling [191] [192] [193] [194] [195] may provide the background for new multivariate modeling approaches that will fit the sepsis phenomenon better than traditional multivariate statistics. Moreover, our theoretical framework needs to be expanded from a linear flow diagram to a more naturalistic web-like representation of human responses to disease. In such frameworks, psychocognitive responses and interactions must be taken into account. 196 
Conclusion
Our increased awareness of the genomic variations as factors in the susceptibility to sepsis further stresses the complex multifactorial nature of the disease and calls for increased efforts to individualize and innovate care in these patients. Nonetheless, genetic association studies in sepsis exhibit methodological limitations, which need to be addressed in the future. In the future, multivariate exploration of the effect of simultaneous variations in a wide array of genes involved in sepsis may provide the basis for genetic counseling in the therapy of the critically ill. However, genetic counseling in critical illness, although partially attainable on the basis of evidence on distinct SNPs, is unlikely to be effective before microarray technology becomes available at the bedside. In addition, complex systems approaches need to be explored in order to expand the current linear theoretical representations of sepsis, which limit our ability to comprehend the pathophysiology of multiple interactions and to devise effective therapeutic approaches. For the time being, there is a lack of bedside tools to aid clinical decision making on the basis of the specific care needs of patients according to their genetic makeup. Nonetheless, experienced critical care nurses may need to remain aware of the potential genetic basis of individual patients' responses to disease and to use sound assessment and judgment skills, to be able to individualize care and maximize patients' chances of recovery, on the basis of their holistic knowledge of the patient. 197 In addition, critical care nursing research may need to explore the efficacy of alternate care plans according to individual genetic predisposition.
